Curis (CRIS) EBITDA Margin Growth (5y) (2015 - 2025)
Curis (CRIS) EBITDA Margin Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Curis | 3.27 Mn | -2.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 193,150.00 |
| Sep 30, 2025 | -4,620.00 |
| Jun 30, 2025 | -7,006.00 |
| Mar 31, 2025 | -11,366.00 |
| Dec 31, 2024 | -4,576.00 |
| Sep 30, 2024 | -17,415.00 |
| Jun 30, 2024 | -19,817.00 |
| Mar 31, 2024 | -28,320.00 |
| Dec 31, 2023 | -26,562.00 |
| Sep 30, 2023 | -21,117.00 |
| Jun 30, 2023 | -21,915.00 |
| Mar 31, 2023 | -10,472.00 |
| Dec 31, 2022 | -13,552.00 |
| Sep 30, 2022 | 14,587.00 |
| Jun 30, 2022 | 667.00 |
| Mar 31, 2022 | -2,930.00 |
| Dec 31, 2021 | 5,481.00 |
| Sep 30, 2021 | 124,918.00 |
| Jun 30, 2021 | 16,984.00 |
| Mar 31, 2021 | 10,824.00 |